COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,300 Articles (22,772 medRxiv, 8,528 bioRxiv)

Most recent first Previous |  Page 2583: Articles 25821-25830  | Next

Dog Savior: Immediate Scent-Detection of SARS-COV-2 by Trained Dogs
Vesga, O., Valencia, A. F., Mira, A., Ossa, F., Ocampo, E., Agudelo Perez, M., Ciouderis, k., Perez, L., Cardona, A., Aguilar Perez, Y., Gonzalez, J. M., Catano Correa, J. C., Agudelo Berruecos, Y., Hernandez-Ortiz, J. P., Osorio, J. E.
10.1101/2020.06.17.158105 — Posted: 2020-06-19 Discussion: Onsite
Antiviral treatment of SARS-CoV-2-infected hamsters reveals a weak effect of favipiravir and a complete lack of effect for hydroxychloroquine
Kaptein, S. J., Jacobs, S., Langendries, L., Seldeslachts, L., ter Horst, S., Liesenborghs, L., Hens, B., Vergote, V., Heylen, E., Maas, E., De Keyzer, C., Bervoets, L., Rymenants, J., Van Buyten, T., Thibaut, H. J., Dallmeier, K., Boudewijns, R., Wouters, J., Augustijns, P., Verougstraete, N., Cawthorne, C., Weynand, B., Annaert, P., Spriet, I., Vande Velde, G., Neyts, J., Rocha-Pereira, J., Delang, L.
10.1101/2020.06.19.159053 — Posted: 2020-06-19
Phylogenetic pattern of SARS-CoV-2 from COVID-19 patients from Bosnia and Herzegovina: lessons learned to optimize future molecular and epidemiological approaches
Goletic, T., Konjhodzic, R., Fejzic, N., Goletic, S., Eterovic, T., Softic, A., Kustura, A., Salihefendic, L., Ostojic, M., Travar, M., Mrdjen, V., Tihic, N., Jazic, S., Musa, S., Marjanovic, D., Hukic, M.
10.1101/2020.06.19.160606 — Posted: 2020-06-19
Disruption of Adaptive Immunity Enhances Disease in SARS-CoV-2 Infected Syrian Hamsters
Brocato, R., Principe, L., Kim, R., Zeng, X., Williams, J., Liu, Y., Li, R., Smith, J., Golden, J., Gangemi, D., Youssef, S., Wang, Z., Glanville, J., Hooper, J.
10.1101/2020.06.19.161612 — Posted: 2020-06-19
High-density amplicon sequencing identifies community spread and ongoing evolution of SARS-CoV-2 in the Southern United States
McNamara, R. P., Caro-Vegas, C., Landis, J. T., Moorad, R., Pluta, L. J., Eason, A. B., Thompson, C., Bailey, A., Villamor, F. C. S., Lange, P. T., Wong, J. P., Seltzer, T., Seltzer, J., Zhou, Y., Vahrson, W., Juarez, A., Meyo, J. O., Calabre, T., Broussard, G., Rivera-Soto, R., Chappell, D. L., Baric, R. S., Damania, B., Miller, M. B., Dittmer, D.
10.1101/2020.06.19.161141 — Posted: 2020-06-19
Multi-pronged human protein mimicry by SARS-CoV-2 reveals bifurcating potential for MHC detection and immune evasion
Venkatakrishnan, A., Kayal, N., Anand, P., Badley, A. D., Soundararajan, V.
10.1101/2020.06.19.161620 — Posted: 2020-06-19
An in-silico based clinical insight on the effect of noticeable CD4 conserved residues of SARS-CoV-2 on the CD4-MHC-I interactions
Chellasamy, S., Arun Kumar, S., Dasgupta, D., Wei, H.
10.1101/2020.06.19.161802 — Posted: 2020-06-19
No evidence of coronaviruses or other potentially zoonotic viruses in Sunda pangolins (Manis javanica) entering the wildlife trade via Malaysia.
Lee, J., Hughes, T., Lee, M.-H., Field, H., Rovie-Ryan, J. J., Sitam, F. T., Sipangkui, S., Nathan, S. K. S. S., Ramirez, D., Kumar, S. V., Lasimbang, H., Epstein, J. H., Daszak, P.
10.1101/2020.06.19.158717 — Posted: 2020-06-19 Discussion: Offsite
Cytosine deamination in SARS-CoV-2 leads to progressive CpG depletion.
Sadykov, M., Mourier, T., Guan, Q., Pain, A.
10.1101/2020.06.19.161687 — Posted: 2020-06-19 Discussion: Offsite
Cross-neutralization activity against SARS-CoV-2 is present in currently available intravenous immunoglobulins
Diez, J. M., Romero, C., Vergara Alert, J., Bello Perez, M., Rodon, J., Honrubia, J. M., Segales, J., Sola, I., Enjuanes, L., Gajardo, R.
10.1101/2020.06.19.160879 — Posted: 2020-06-19

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).